Vimarsana
Biggest News Aggregation in the World

Page 5 - Alacyclovir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alacyclovir Today - Breaking & Trending Today

People With Liver Disease Can Now Take Remdesivir for COVID - Vimarsana News

People With Liver Disease Can Now Take Remdesivir for COVID

The move is important because, previously, some people with liver disease had limited treatment options for severe cases of COVID-19.

Gilead Quarterly Profit Falls on COVID Sales Drop - Vimarsana News

Gilead Quarterly Profit Falls on COVID Sales Drop

Gilead Sciences reported lower second-quarter profit as costs from a legal settlement and sharply lower sales of its COVID-19 treatment offset another strong performance by HIV drugs.

Bulevirtide for Hep D: Phase 3 Data Now Published in NEJM - Vimarsana News

Bulevirtide for Hep D: Phase 3 Data Now Published in NEJM

Bulevirtide, an investigational, first-in-class hepatitis delta virus entry-inhibitor, significantly reduced viral load and normalized liver enzymes in patients.

Shingles Infection Rates Higher in Patients With MS - Vimarsana News

Shingles Infection Rates Higher in Patients With MS

"The take-home finding is that herpes zoster incidence is high among people with MS overall."

New Drugs in Primary Care: Lessons Learned From COVID-19 - Vimarsana News

New Drugs in Primary Care: Lessons Learned From COVID-19

"Although the details are not important for prescribing internists, having a basic understanding of the mechanism of action can help [us] better understand for which patients the drugs are indicated."